Patent details

EP2265125 Title: TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS

Basic Information

Publication number:
EP2265125
PCT Application Number:
US2009002389
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097335095
PCT Publication Number:
WO2009128934
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS
French Title of Invention:
ANTAGONISTES DE LFA-1 TOPIQUES UTILISÉS DANS LE TRAITEMENT LOCALISÉ DE TROUBLES DE NATURE IMMUNITAIRE
German Title of Invention:
TOPISCHE LFA-1-ANTAGONISTEN ZUR VERWENDUNG BEI DER LOKALEN BEHANDLUNG VON IMMUNERKRANKUNGEN
SPC Number:

Dates

Filing date:
15/04/2009
Grant date:
14/08/2019
EP Publication Date:
29/12/2010
PCT Publication Date:
22/10/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/08/2019
EP B1 Publication Date:
14/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/04/2020
Expiration date:
15/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/08/2019
 
 

Name:
SARcode Bioscience Inc.
Address:
1000 Marina Blvd., Suite 250, Brisbane, CA 94005, United States (US)

Inventor

1

Name:
BURNIER, John
Address:
United States (US)

2

Name:
GADEK, Thomas
Address:
United States (US)

Priority

Priority Number:
45240
Priority Date:
15/04/2008
Priority Country:
United States (US)

Classification

IPC classification:
A01N 55/02; A61K 9/00; A61K 31/472; A61K 31/4725; A61K 31/555; A61K 38/13; A61P 11/00; A61P 17/00; A61P 17/06; A61P 17/14; A61P 19/02; A61P 29/00;

Publication

European Patent Bulletin

1

Issue number:
201933
Publication date:
14/08/2019
Description:
Grant (B1)

2

Issue number:
201938
Publication date:
18/09/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages